KK
AXSM icon

KLP Kapitalforvaltning’s Axsome Therapeutics AXSM Stock Holding History

KLP Kapitalforvaltning’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Hold
9,200
– – 0.01% 719
2026
Q1 		$1.55M Buy
9,200
+200
+2% +$34.5K 0.01% 820
2025
Q4 		$1.64M Hold
9,000
– – 0.01% 799
2025
Q3 		$1.09M Sell
9,000
-2,200
-20% -$248K ﹤0.01% 979
2025
Q2 		$1.17M Buy
11,200
+3,000
+37% +$318K 0.01% 895
2025
Q1 		$956K Sell
8,200
-600
-7% -$68.4K ﹤0.01% 958
2024
Q4 		$745K Buy
+8,800
New +$809K ﹤0.01% 1131

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

KLP Kapitalforvaltning's AXSM Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 9,200 shares worth $2.25M. The position accounts for 0.01% of the portfolio, ranked #719.

KLP Kapitalforvaltning first reported a position in AXSM in Q4 2024 and has held it in 7 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • KLP Kapitalforvaltning held 9,200 shares of Axsome Therapeutics worth $2.25M as of Q2 2026.
  • KLP Kapitalforvaltning left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #719 holding.
  • KLP Kapitalforvaltning first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.